Pacific Capital Partners Ltd Acquires Shares of 10,000 Humana Inc. $HUM

Pacific Capital Partners Ltd bought a new position in shares of Humana Inc. (NYSE:HUM) during the third quarter, HoldingsChannel.com reports. The firm bought 10,000 shares of the insurance provider’s stock, valued at approximately $2,602,000. Humana accounts for approximately 2.9% of Pacific Capital Partners Ltd’s portfolio, making the stock its 16th biggest position.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HUM. Elevation Point Wealth Partners LLC bought a new stake in shares of Humana in the second quarter valued at approximately $32,000. Mather Group LLC. acquired a new position in Humana in the 3rd quarter valued at $34,000. Private Wealth Management Group LLC lifted its position in shares of Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 48 shares during the period. AlphaCore Capital LLC bought a new stake in shares of Humana during the 2nd quarter valued at $39,000. Finally, SJS Investment Consulting Inc. grew its holdings in shares of Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after purchasing an additional 193 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Down 1.0%

Shares of HUM opened at $273.96 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The stock has a market capitalization of $32.95 billion, a price-to-earnings ratio of 25.68, a PEG ratio of 2.28 and a beta of 0.45. The stock has a fifty day moving average of $254.06 and a 200-day moving average of $263.12.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.Humana’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.16 EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is 33.18%.

Analyst Ratings Changes

A number of research analysts recently commented on HUM shares. Wells Fargo & Company downgraded Humana from an “overweight” rating to a “cautious” rating in a research note on Wednesday, January 7th. Morgan Stanley restated an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. The Goldman Sachs Group cut their price target on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a report on Monday, November 24th. Wolfe Research decreased their price objective on shares of Humana from $313.00 to $300.00 and set an “outperform” rating on the stock in a research note on Thursday, November 20th. Finally, Evercore ISI assumed coverage on shares of Humana in a research report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price objective for the company. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $292.05.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.